US Patent Issued to TRITERPENOID THERAPEUTICS on June 9 for "Analogs of CDDO-2P-Im and CDDO-3P-Im" (Vermont Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,763, issued on June 9, was assigned to TRITERPENOID THERAPEUTICS INC. (Lebanon, N.H.).

"Analogs of CDDO-2P-Im and CDDO-3P-Im" was invented by Michael B. Sporn (Tunbridge, Vt.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to synthetic triterpenoids, methods for preparing such synthetic triterpenoids, and methods of using such synthetic triterpenoids to treat and/or prevent diseases or disorders such as cancers, particularly brain tumors, neuropsychiatric disorders, and neurodegenerative diseases."

The patent was filed on Sept. 14, 2021, under Application No. 18/245,109.

*For further information, including images, char...